NINA TANDON is at the cutting edge of science where sci-fi meets reality. She works on growing artificial hearts and bones that can be put into the body, and studies the new frontier of biotech: homes, textiles, and videogames made of cells. Named one of Fast Company’s Most Creative People in Business, and one of Foreign Policy’s 100 Leading Global Thinkers, Tandon speaks on the future of healthcare and technology.
Nina Tandon is leading the charge of biology’s industrial revolution. She is the founder and CEO of EpiBone, the world’s first company growing living human bone for skeletal reconstruction. The benefits of this revolutionary stem cell technology, which has already been approved by the FDA for clinical trial, include simplified surgery, improved bone formation, and shorter recovery times for patients. “Being able to use your own cells means you’re empowered to heal yourself as well,” says Tandon, who also co-authored Super Cells: Building with Biology, a book cataloguing the latest biotech inventions “using nature’s building block: the cell.”
A TED Senior Fellow (she’s spoken at three different TED conferences) and Adjunct Professor of Electrical Engineering at the Cooper Union, Tandon has a Bachelor’s in Electrical Engineering from the Cooper Union, a Master’s in Bioelectrical Engineering from MIT, a PhD in Biomedical Engineering, and an MBA from Columbia University. Her PhD research focused on studying electrical signaling in the context of tissue engineering, and has worked with cardiac, skin, bone, and neural tissue.
After completing her PhD, she consulted at McKinsey and Company, but since 2010 she has continued her work in tissue engineering. She has been published in Nature Protocols and Lab on a Chip and has been featured on CNN, in WIRED, the Guardian, and others. Tandon was named one of the 100 Most Creative People in Business by Fast Company, a Crain’s 40 under 40 people who have achieved success in business before turning 40, and a World Economic Forum Tech Pioneer.